Federal award (PURCHASE ORDER, fiscal year 2024)
Recipient: OXFORD NANOPORE TECHNOLOGIES INC
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2025-04-25 to 2026-04-24
Current total value of award: $15000
Description: THE LICENSE IS NEEDED TO PROVIDE SUPPORT FOR THE INSTRUMENT THAT HAS BEEN USED FOR THE LAB PROJECTS TO CONTINUE ONGOING STUDY THE ROLE OF HERV-K ACTIVATION IN ALS PATHOLOGY AS WELL AS HIV RESERVOIR INFORMATION IN HIV PATIENTS.